AGI Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AGI Therapeutics - overview
Location
Dublin, -, Ireland
Primary Industry
Pharmaceuticals
About
AGI Therapeutics is an Ireland-based pharmaceutical company.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.agitherapeutics.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
AGI Therapeutics - financials
| Fiscal Year Ended | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 196,000 | 392,000 | 577,000 | 320,000 | 67,000 | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | 100.0% | 47.2% | (44.5%) | (79.1%) | (100.0%) | - | - | - | - | - |
| EBITDA (USD) | 2,169,000 | (15,327,000) | (18,653,000) | (10,666,000) | (3,510,000) | (1,957,000) | (1,033,000) | - | - | - | - |
| Operating Income (USD) | 1,064,000 | (15,407,000) | (18,833,000) | (10,831,000) | (3,610,000) | (2,002,000) | (1,033,000) | - | - | - | - |
| Operating Margin | 542.9% | (3930.4%) | (3264.0%) | (3384.7%) | (5388.1%) | - | - | - | - | - | - |
| % EBITDA Margin | 1106.6% | (3909.9%) | (3232.8%) | (3333.1%) | (5238.8%) | - | - | - | - | - | - |
| NET Income (USD) | (4,322,000) | (14,068,000) | (18,203,000) | (10,638,000) | (3,602,000) | (2,089,000) | (1,031,000) | - | - | - | - |
| % Net Margin | (2205.1%) | (3588.8%) | (3154.8%) | (3324.4%) | (5376.1%) | - | - | - | - | - | - |
AGI Therapeutics - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | AGI Therapeutics | - | ||||||||
| Series A | Completed | AGI Therapeutics | - |
Displaying 1 - 2 of 2
AGI Therapeutics - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.